chartexchange

RAIN
Rain Enhancement Technologies Holdco, Inc. Class A Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:15 PM EDT
0.78USD-6.988%(-0.06)124,221
Pre-marketOct 2, 2026 8:37:30 AM EDT
0.8365USD-0.417%(-0.0035)
After-hoursOct 2, 2026 4:50:30 PM EDT
0.805USD+3.033%(+0.024)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Newark, CA, USA
Previous Close
$0.84
Beta
1.19
52-Week High
$8.52 2025-12-22
52-Week Low
$0.65 2026-09-18
SMA 50
$0.99
SMA 200
$2.33
Avg. Vol 10D
6.95M
Avg. Vol 30D
2.53M
Avg. Vol 90D
1.22M
Relative Vol
0.05
2.01M
235.5500%
67,191
Nov 12, 2026 (38d)
RAIN Profile

rain therapeutics is a san francisco bay area-based biotechnology company, focused on developing small molecule targeted therapeutics for cancer patients that possess a clear, and single, oncogenic driver.

RAIN Performance
PeriodPriceDateChangeBeta
1W0.912026-09-28-13.98%-1.307
1M0.852026-09-04-8.21%1.287
3M1.952026-07-06-59.93%0.415
6M2.712026-04-06-71.17%1.076
1Y4.832025-10-03-83.82%1.191
2Y7.302025-01-02-89.30%—
5Y14.732021-10-04-94.70%0.582
RAIN Stock Summary

Rain Enhancement Technologies Holdco, Inc. Class A Common Stock (NASDAQ:RAIN) stock price today is $0.78, and today's volume is 124,489. RAIN is down 6.610% today. The 30 day average volume is 2.53M. RAIN market cap is $9.14M with 11.70M shares outstanding.